Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT03431649 Completed - Clinical trials for Pediatric Pulmonary Hypertension

Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children

Start date: April 1, 2017
Phase: Phase 4
Study type: Interventional

To analyze the efficacy of beraprost and sildenafil for treatment of pulmonary hypertension in children with left to right shunt. analyze the efficacy and side effects.

NCT ID: NCT03431376 Completed - Hypertension Clinical Trials

Potato Consumption and Risk of Hypertension

Start date: January 1, 1989
Phase: N/A
Study type: Observational

Government has popularized potatoes as a major staple food in China. Potato, a potassium-rich food with high glycemic responses after consumption, exhibits unclear effects on hypertension. In this study, the investigators aimed to examine the association between potato consumption and hypertension risk among Chinese people.

NCT ID: NCT03422185 Completed - Hypertension Clinical Trials

Understanding Local Determinants of Cardiovascular Disease and Diabetes

Start date: May 2013
Phase: N/A
Study type: Observational

Cross-sectional survey of all adults residing in two defined geographical regions in urban Lilongwe and rural Karonga District. Participants were interviewed, had anthropometric measures taken, and had fasting blood specimens taken.

NCT ID: NCT03412552 Completed - Clinical trials for Hypertensive Disorder of Pregnancy

Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia

Start date: October 1, 2015
Phase: N/A
Study type: Observational

Laboratory monitoring of patients included serial measurement of complete blood cell count, liver function tests, coagulation profile, and renal function tests. ICU management during conduction of the research study included the following: Control of convulsions using magensium sulphate. Control of blood pressure Diastolic blood pressure above 110 mmHg, nifedipine was administered.A plasma volume expansion with saline was used in all women to maintain sufficient intravascular volume. Delivery was performed immediately after hemodynamic stabilization and clinical control of general condition .

NCT ID: NCT03403166 Completed - Blood Pressure Clinical Trials

Metabolomics of the Dietary Approaches to Stop Hypertension (DASH) Dietary Pattern

Start date: August 1993
Phase: N/A
Study type: Observational

The present record represents a secondary data analysis of the Dietary Approaches to Stop Hypertension (DASH) trial. Study data and specimens were accessed through the National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Coordinating Center (BioLINCC). A global, untargeted, metabolomic profile was used to investigate biomarkers of the DASH dietary pattern as well as blood pressure change.

NCT ID: NCT03396120 Completed - Clinical trials for Pulmonary Hypertension

The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease

Start date: February 2, 2017
Phase: N/A
Study type: Observational

Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is recommended for early detection of PH because of its potentially significant impact on treatment strategy and clinical outcomes. Objectives: To evaluate the usefulness of assessing forced vital capacity (FVC%), diffusion capacity of the lung for carbon monoxide (DLCO%), and FVC%/DLCO% ratio to predict pulmonary hypertension among patients with ILDs.

NCT ID: NCT03395535 Completed - Ocular Hypertension Clinical Trials

Laser-1st vs Drops-1st for Glaucoma and Ocular Hypertension

LIGHT
Start date: October 1, 2012
Phase: Phase 4
Study type: Interventional

This is a randomized study with two treatment arms: 'initial Selective Laser Trabeculoplasty (SLT) followed by conventional medical therapy as required' ('Laser-1st') and 'medical therapy without laser ('Medicine-1st'). It compares quality of life in the two arms at three years, while also examining the incremental cost and cost-effectiveness of Laser-1st versus Medicine-1st.

NCT ID: NCT03393715 Completed - Hypertension Clinical Trials

Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

CHRONIC1
Start date: February 2016
Phase: Phase 4
Study type: Interventional

We assessed the influence of time of administration of ACE inhibitors on circadian blood pressure control in sub Saharan type 2 diabetes patients with stage 1 hypertension over 56 days as first line treatment.

NCT ID: NCT03392350 Completed - Hypertension Clinical Trials

Randomized Trial of the Impact of Body Scanning and Intensive Behavioral Intervention on Behavioral Change and Health Outcomes

Start date: June 15, 2012
Phase: N/A
Study type: Interventional

We evaluated the effectiveness of a combination of a comprehensive health assessment consisting of the combination of a screening full body scan employing graphic patient education and motivational techniques followed by intensive, individualized behavioral training and management program on improved adherence to beneficial lifestyle behaviors, as well as possibly reduced risk of disease.

NCT ID: NCT03385070 Completed - Lens Opacities Clinical Trials

Salt Sensitivity Hypertension and Lens Opacities

Start date: March 15, 2017
Phase: N/A
Study type: Observational [Patient Registry]

Salt-sensitive hypertension (SSH) accounts for about the half of all Hypertension (HT) cases .In SSH, Na+/K+-ATPase activity is impaired. Impaired Na+/K+-ATPase activity in the lens epithelium results in cortical opacities in the peripheral equator of the lens. This study analyzed 305 patients with hypertension aged between 40 and 80 years and 124 non-HT controls. A total of 163 patients with HT who were admitted to the emergency service at least once with a minimum increase of 10% in their systolic and diastolic blood pressure after consuming salted food met the eligible criteria for HT and were included in the SSH group. A total of 142 patients who were previously diagnosed with HT but had no previous history were considered non-SSH. Two researchers examined the presence of cortical lens opacities biomicroscopically using the diffuse, direct, Scheimpflug, and retroillumination from fundus methods.